Ramipril and Olmesartan: Unveiling their pleiotropic potential as immunomodulators

Jyothishna Dasan, Anie Yesunesan, Vinaya Chandran, Jyothis Mathew, Linu Mathew · 2026

Read Ramipril and Olmesartan: Unveiling their pleiotropic potential as immunomodulators by Jyothishna Dasan, Anie Yesunesan, Vinaya Chandran, Jyothis Mathew, Linu Mathew (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13610802.txt.

Description

Jyothishna Dasan and co-authors test whether two common blood pressure drugs also calm the immune system. The 2026 study uses rats to check ramipril and olmesartan, two drugs long used for high blood pressure. Both drugs are known to lower a blood marker of swelling, which hints at wider effects.

In tests of short and long term swelling, both drugs cut paw swelling and improved tissue health. They also helped immune cells stick and fight, raised antibody levels, and shifted key signal proteins toward calm. At matched doses for blood pressure, olmesartan showed the stronger immune effect. The authors suggest such dual action could help patients who have both high blood pressure and swelling.

Catalog record

CREATORJyothishna Dasan, Anie Yesunesan, Vinaya Chandran, Jyothis Mathew, Linu Mathew
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE23 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13610802

Browse the full library · About the Tower of Babel